Objective Therapeutic hypothermia (TH) for neonatal hypoxic-ischaemic encephalopathy
(HIE), delivered mainly in tertiary cooling centres (CCs), reduces mortality and …

Objective Therapeutic hypothermia (TH) commenced soon after birth for neonatal hypoxic
ischaemic encephalopathy (HIE) improves survival and reduces neurodisability. Availability …

Objective To compare therapeutic hypothermia (TH) treatment of term and near-term
neonates with hypoxic-ischemic encephalopathy (HIE) between neonatal units. Study …

Objective Hypoxic-ischaemic encephalopathy (HIE) remains a leading cause of neonatal
mortality and neurodisability. We aimed to determine the incidence of HIE and management …

Objective The use of therapeutic hypothermia (TH) for mild hypoxic–ischaemic
encephalopathy (HIE) remains controversial and inconsistent. We analysed trends in TH …

Objective To characterize variations in practices and outcomes for neonates with hypoxic-
ischemic encephalopathy (HIE) treated with therapeutic hypothermia (TH) across Canadian …

Background Therapeutic hypothermia is standard of care for babies with moderate/severe
hypoxic-ischaemic encephalopathy and is increasingly used for mild encephalopathy …

Background Although shown to reduce death or disability in moderate-to-severe hypoxic
ischaemic encephalopathy (HIE), therapeutic hypothermia (TH) has recently been …

BACKGROUND: Birth asphyxia in term neonates remains a serious condition that causes
significant mortality and longterm neurodevelopmental sequelae despite hypothermia …

Objective To re-visit short-term outcomes and associated risk factors of newborns with
hypoxic-ischemic encephalopathy (HIE) in an era where hypothermia treatment (HT) is …